|
Non-Hodgkins Lymphoma News - Return to News Menu
NON-HODGKIN'S LYMPHOMA SEMINAR TODAY
November 12, 2004 The director of clinical operations of the lymphoma and myeloma center at M.D. Anderson Cancer Center in Houston will be the featured speaker on non-Hodgkin's lymphoma at 9:30 a.m. Saturday at the Potpourri House, 3320 Troup Highway.
Dr. Luis E. Fayad, assistant professor of medicine, will speak at a "Meet The Expert on Non-Hodgkin's Lymphoma" meeting, sponsored by The Leukemia and Lymphoma Society of Northeast Texas. The meeting is free.
He will discuss cancers affecting the blood cells and explain specialized treatment at M.D. Anderson for this disease.
Shelby Brangan, patient services coordinator for The Leukemia and Lymphoma Society in Dallas, said, "Dr. Fayad will share basic information on terminology, risk factors, diagnosis, staging and classification as well as discuss new insights and treatments."
She added, "Dr. Fayad, who will be speaking and sharing his knowledge of the disease, is a respected cancer researcher at The University of Texas M.D. Anderson Cancer Center. This session will provide valuable information and the latest news on research and treatment for non-Hodgkin's lymphoma patients looking to learn more about their disease."
She said the meeting will be a valuable and educational tool to help improve the quality of life of patients and their families who are battling blood cancers.
She said NHL is a diverse group of cancers which develop in the lymphatic system. The annual incidence of lymphoma has nearly doubled over the last 35 years. Approximately 300,000 people are living with NHL, the fifth most common cancer in the U.S.
She said lymphoma is the most common blood cancer and the third most common cancer of childhood.
There are approximately 62,250 new cases of lymphoma diagnosed each year and nearly 20,700 people will die from the disease.
She said, "The mission of the Lymphoma Research Foundation is to eradicate lymphoma and serve those touched by the disease. The Foundation is the nation's largest lymphoma-focused voluntary health organization devoted exclusively to funding lymphoma research and providing patients and healthcare professionals with critical information on the disease."
She said LRF has funded more than $18 million in lymphoma research, with 89 cents of every dollar raised going to research and education programming. People affected by lymphoma can receive free personalized information tailored to their diagnosis, help with finding a clinical trial, and easy-to-understand information on lymphoma, current treatments, and promising research.
|
